Pharmetheus Ab
Pharmetheus AB, a leading name in the biopharmaceutical industry, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in 2012, the company has established itself as a pioneer in pharmacometrics, offering innovative solutions in model-informed drug development and regulatory submissions. Pharmetheus provides a unique blend of services, including population pharmacokinetics, pharmacodynamics, and quantitative systems pharmacology, which set them apart in the competitive landscape. Their commitment to advancing drug development processes has garnered recognition, positioning them as a trusted partner for pharmaceutical companies aiming to optimise their clinical trials and improve patient outcomes. With a focus on scientific excellence and collaboration, Pharmetheus continues to achieve significant milestones in the realm of drug development.
DitchCarbon Score
How does Pharmetheus Ab's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmetheus Ab's score of 26 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmetheus Ab's reported carbon emissions
In 2022, Pharmetheus Ab reported total carbon emissions of approximately 77,980 kg CO2e. This figure represents the company's overall emissions without specific breakdowns into Scope 1, 2, or 3 categories, as no detailed scope data has been disclosed. Currently, Pharmetheus Ab does not have any publicly stated reduction targets or climate pledges, indicating a potential area for future commitment. The absence of specific initiatives or targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. As Pharmetheus Ab is headquartered in Sweden (SE), it operates within a region that is increasingly focused on sustainability and carbon reduction. However, without further data or commitments, the company's climate impact and future plans remain unclear.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmetheus Ab is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
